Comparison of oral and intravenous iron for the prevention and management of iron deficiency anaemia in pregnancy: a systematic review and meta-analysis
DOI:
https://doi.org/10.18203/2320-6012.ijrms20262191Keywords:
Iron-deficiency anemia, Pregnancy, Intravenous iron, Oral iron, Randomized controlled trialsAbstract
Iron-deficiency anaemia (IDA) affects nearly 38% of pregnant women worldwide and is linked to maternal complications and poor birth outcomes. Although oral iron is the standard treatment, its use is often limited by gastrointestinal side effects and poor adherence. Intravenous (IV) iron may offer faster and better-tolerated correction of anaemia. This systematic review and meta-analysis compared IV and oral iron for the prevention and management of IDA in pregnancy. This review was registered with PROSPERO and conducted according to PRISMA guidelines. A total of 4,216 articles were screened, and 17 eligible studies, including 16 randomized controlled trials, were included. Two reviewers independently performed data extraction and quality assessment. Random-effects meta-analysis using the DerSimonian and Laird method was conducted. Primary outcomes were haemoglobin and serum ferritin; secondary outcomes included maternal and neonatal outcomes and treatment-related adverse events. IV iron produced significantly greater improvements in haemoglobin (mean difference 0.7 g/dl; 95% CI: 0.4-1.0) and serum ferritin (mean difference 79.4 ng/ml; 95% CI: 21.8-137) than oral iron. The odds of maternal anemia were reduced by 71% with IV therapy (OR 0.29; 95% CI: 0.08-1.00). No significant differences were observed in cord haemoglobin or cord ferritin, although ferritin showed a favourable non-significant trend. Adverse events were less frequent with IV iron, but the difference was not statistically significant. IV iron was more effective than oral iron in improving haematological outcomes in pregnant women with IDA and may be preferred in moderate-to-severe anemia, oral iron intolerance, or late gestation.
References
DeLoughery EP. Global prevalence of anemia among women of reproductive age, 2000-2019. Eur J Haematol. 2024;113(2):253-6.
National Family Health Survey (NFHS-5) Phase II. Available at https://www.mohfw.gov.in/sites/default/files/NFHS-5_Phase-II_0.pdf. Accessed on 30 March 2026.
Bothwell TH. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr. 2000;72(1):257S-64.
Peña-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;(7):CD004736.
Rahman MM, Abe SK, Rahman MS, Kanda M, Narita S, Bilano V, et al. Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis. Am J Clin Nutr. 2016;103(2):495-504.
Bencaiova G, Breymann C. Mild anemia and pregnancy outcome in a Swiss collective. J Pregnancy. 2014;2014:307535.
WHO. Guideline: daily iron and folic acid supplementation in pregnant women. Available at :https://www.who.int/publications/i/item/9789241501996. Accessed on 30 March 2026.
Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):31-8.
Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J. Investigators on behalf of the FER-ASAP. Ferric carboxymaltose vs oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial. J Perinat Med. 2017;45(4):443-53.
Broche N, Raczynski R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG. 2006;113(11):1258-62.
Westad S, Backe B, Salvesen KA, Nakling J, Okland I, Borthen I, et al. A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia. Acta Obstet Gynecol Scand. 2008;87(9):916-23.
Das SN, Devi A, Mohanta BB, Choudhury A, Swain A, Thatoi PK. Oral versus intravenous iron therapy in iron deficiency anemia: an observational study. J Fam Med Prim Care. 2020;9(7):3619-23.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
Godin K, Stapleton J, Kirkpatrick SI, Hanning RM, Leatherdale ST. Applying systematic review search methods to the grey literature: a case study examining guidelines for school-based breakfast programs in Canada. Syst Rev. 2015;4:138.
McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40-6.
WHO. The global prevalence of anaemia in 2011. Available at https://www.who.int/publications/i/item/9789241564960. Accessed on 30 March 2026.
Li T, Vedula SS, Scherer R, Dickersin K. What comparative effectiveness research is needed? A framework for using guidelines and systematic reviews to identify evidence gaps and research priorities. Ann Intern Med. 2012;156(5):367-77.
Barker TH, Stone JC, Sears K, Klugar M, Tufanaru C, Leonardi-Bee J, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid Synth. 2023;21(3):494-506.
Dura MC, Dundar IY, Aslan O, Yildiz S, Ekin GU, Ekin M. Comparison of the anaemia and transfusion rates of pregnant women treated with intravenous versus oral iron in the third trimester. J Coll Physicians Surg Pak. 2024;34(10):1183-8.
Pasricha SR, Mwangi MN, Moya E, Ataide R, Mzembe G, Harding R, et al. Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial. Lancet. 2023;401(10388):1595-609.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88.
Lewkowitz AK, Gupta A, Simon L, Sabol BA, Stoll C, Cooke E, et al. Intravenous compared with oral iron for the treatment of iron-deficiency anemia in pregnancy: a systematic review and meta-analysis. J Perinatol. 2019;39(4):519-32.
Jose A, Mahey R, Sharma JB, Bhatla N, Saxena R, Kalaivani M, et al. Comparison of ferric carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy: randomised controlled trial. BMC Pregnancy Childbirth. 2019;19(1):54.
Afolabi BB, Babah OA, Adeyemo TA, Balogun M, Banke-Thomas A, Abioye AI, et al. Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial. Lancet Glob Health. 2024;12(10):e1649-59.
Khalafallah AA, Hyppa A, Chuang A, Hanna F, Wilson E, Kwok C, et al. A prospective randomised controlled trial of a single intravenous infusion of ferric carboxymaltose vs single intravenous iron polymaltose or daily oral ferrous sulphate in the treatment of iron deficiency anaemia in pregnancy. Semin Hematol. 2018;55(4):223-34.
Thobbi VA, Bijapur ZNM. A comparative study of efficacy, safety and compliance of oral iron versus intravenous iron sucrose in treatment of iron deficiency anaemia of pregnancy. Int J Reprod Contracept Obstet Gynecol. 2020;9(9):3852-7.
Tonge G, Dasila PS, Pote T. Oral versus intravenous iron therapy among pregnant women with iron deficiency anaemia: a comparative study. Int J Reprod Contracept Obstet Gynecol. 2023;12(5):1384-9.
Chauhan N, Dogra P, Sharma R, Kant S, Soni M. Randomized controlled trial comparing ferrous sulfate and iron sucrose in iron deficiency anemia in pregnancy. Cureus. 2023;15(2):e35490.
Abdelazim I, Abu-Faza M, Elbiaa Assem AM, Othman H, Alsharif D, Elsawah W. Heme iron polypeptide (Proferrin-ES) versus iron saccharate complex (Ferrosac) for treatment of iron deficiency anemia during pregnancy. Acta Med Int. 2017;4(1):56-62.
Chawla S, Singh A, Jhamb D, Anupama CH. A randomised controlled trial to compare injection ferric carboxymaltose and oral iron in treating iron deficiency anemia during pregnancy. J Obstet Gynecol India. 2022;72(6):492-6.
Ruangvutilert P, Chanprapaph P, Chuenwattana P, Titapant V, Komoltri C. Low-dose weekly intravenous iron sucrose versus daily oral iron for iron deficiency anemia in late pregnancy: a randomized controlled trial. J Med Assoc Thai. 2017;100(5):496-503.
Arzoo S, Yousof S, Rahman J, Chowdhury S. Iron deficiency anemia in pregnancy: intravenous iron sucrose versus oral iron sulfate. Bangladesh J Obstet Gynaecol. 2020;33(1):40-4.
Tigga M, Debbarma A. A comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of Northeast India. Tzu Chi Med J. 2020;32(3):258-62.
Rudra S, Chandna A, Nath J. Comparison of intravenous iron sucrose with oral iron in pregnant women with iron deficiency anaemia. Int J Reprod Contracept Obstet Gynecol. 2016;5(3):747-51.
Bhavi SB, Jaju PB. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy: a randomized controlled trial. BMC Pregnancy Childbirth. 2017;17(1):137.
Radhika AG, Sharma AK, Perumal V, Sinha A, Sriganesh V, Kulshreshtha V, et al. Parenteral versus oral iron for treatment of iron deficiency anaemia during pregnancy and post-partum: a systematic review. J Obstet Gynaecol India. 2019;69(1):13-24.
Rogozińska E, Daru J, Nicolaides M, Amezcua-Prieto C, Robinson S, Wang R, et al. Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis. Lancet Haematol. 2021;8(7):e503-12.
Govindappagari S, Burwick RM. Treatment of iron deficiency anemia in pregnancy with intravenous versus oral iron: systematic review and meta-analysis. Am J Perinatol. 2019;36(4):366-76.
Qassim A, Grivell RM, Henry A, Kidson-Gerber G, Shand A, Grzeskowiak LE. Intravenous or oral iron for treating iron deficiency anaemia during pregnancy: systematic review and meta-analysis. Med J Aust. 2019;211(8):367-73.
Muñoz M, Peña-Rosas JP, Robinson S, Milman N, Holzgreve W, Breymann C, et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement. Transfus Med. 2018;28(1):22-39.
Lewkowitz AK, Stout MJ, Cooke E, Stoll C, Tuuli MG. Intravenous versus oral iron for iron-deficiency anemia in pregnancy: a randomized trial. Am J Obstet Gynecol MFM. 2022.